Monocyte and macrophage dynamics during atherogenesis.

Vascular inflammation is associated with and in large part driven by changes in the leukocyte compartment of the vessel wall. Here, we focus on monocyte influx during atherosclerosis, the most common form of vascular inflammation. Although the arterial wall contains a large number of resident macrophages and some resident dendritic cells, atherosclerosis drives a rapid influx of inflammatory monocytes (Ly-6C(+) in mice) and other monocytes (Ly-6C(-) in mice, also known as patrolling monocytes). Once in the vessel wall, Ly-6C(+) monocytes differentiate to a phenotype consistent with inflammatory macrophages and inflammatory dendritic cells. The phenotype of these cells is modulated by lipid uptake, Toll-like receptor ligands, hematopoietic growth factors, cytokines, and chemokines. In addition to newly recruited macrophages, it is likely that resident macrophages also change their phenotype. Monocyte-derived inflammatory macrophages have a short half-life. After undergoing apoptosis, they may be taken up by surrounding macrophages or, if the phagocytic capacity is overwhelmed, can undergo secondary necrosis, a key event in forming the necrotic core of atherosclerotic lesions. In this review, we discuss these and other processes associated with monocytic cell dynamics in the vascular wall and their role in the initiation and progression of atherosclerosis.

[1]  K. Ley,et al.  How dendritic cells shape atherosclerosis. , 2011, Trends in immunology.

[2]  N. Kalia,et al.  Endothelial cell-borne platelet bridges selectively recruit monocytes in human and mouse models of vascular inflammation. , 2011, Cardiovascular research.

[3]  K. Ley,et al.  Mycophenolate mofetil decreases atherosclerotic lesion size by depression of aortic T-lymphocyte and interleukin-17-mediated macrophage accumulation. , 2011, Journal of the American College of Cardiology.

[4]  M. Cathcart,et al.  &agr;M&bgr;2 Integrin Activation Prevents Alternative Activation of Human and Murine Macrophages and Impedes Foam Cell Formation , 2011, Circulation research.

[5]  D. Ron,et al.  Integrating the mechanisms of apoptosis induced by endoplasmic reticulum stress , 2011, Nature Cell Biology.

[6]  K. Moore,et al.  Role of Toll-Like Receptor 4 in Intimal Foam Cell Accumulation in Apolipoprotein E–Deficient Mice , 2011, Arteriosclerosis, thrombosis, and vascular biology.

[7]  B. Pence,et al.  Adding exercise to rosuvastatin treatment: influence on C-reactive protein, monocyte toll-like receptor 4 expression, and inflammatory monocyte (CD14+CD16+) population. , 2010, Metabolism: clinical and experimental.

[8]  Chaowei Wu,et al.  LXR promotes the maximal egress of monocyte-derived cells from mouse aortic plaques during atherosclerosis regression. , 2010, The Journal of clinical investigation.

[9]  K. Moore,et al.  Atherogenic lipids and lipoproteins trigger CD36-TLR2-dependent apoptosis in macrophages undergoing endoplasmic reticulum stress. , 2010, Cell metabolism.

[10]  Oliver Soehnlein,et al.  Hyperlipidemia-Triggered Neutrophilia Promotes Early Atherosclerosis , 2010, Circulation.

[11]  M. Fessler,et al.  Macrophage ABCA1 reduces MyD88-dependent Toll-like receptor trafficking to lipid rafts by reduction of lipid raft cholesterol[S] , 2010, Journal of Lipid Research.

[12]  S. Theocharis,et al.  Toll-Like Receptor 4 Immunohistochemical Expression Is Enhanced in Macrophages of Symptomatic Carotid Atherosclerotic Plaques , 2010, Cerebrovascular Diseases.

[13]  C. Serhan Novel lipid mediators and resolution mechanisms in acute inflammation: to resolve or not? , 2010, The American journal of pathology.

[14]  M. Kitakaze,et al.  The Role of Endoplasmic Reticulum Stress in the Progression of Atherosclerosis , 2010 .

[15]  J. Casanova,et al.  Human CD14dim Monocytes Patrol and Sense Nucleic Acids and Viruses via TLR7 and TLR8 Receptors , 2010, Immunity.

[16]  Michael R. Elliott,et al.  Identification of a Novel Macrophage Phenotype That Develops in Response to Atherogenic Phospholipids via Nrf2 , 2010, Circulation research.

[17]  C. Serhan,et al.  Profiling in resolving inflammatory exudates identifies novel anti‐inflammatory and pro‐resolving mediators and signals for termination , 2010, Journal of internal medicine.

[18]  A. Tall,et al.  ATP-Binding Cassette Transporters and HDL Suppress Hematopoietic Stem Cell Proliferation , 2010, Science.

[19]  David M. Mosser,et al.  Exploring the full spectrum of macrophage activation , 2010, Nature Reviews Immunology.

[20]  Kristina M. Little,et al.  Cxc Chemokine Ligand 4 Induces a Unique Transcriptome in Monocyte-derived Macrophages Address Correspondence and Reprint Requests To , 2022 .

[21]  Qing Xu,et al.  Native Low-Density Lipoprotein Uptake by Macrophage Colony-Stimulating Factor-Differentiated Human Macrophages Is Mediated by Macropinocytosis and Micropinocytosis , 2010, Arteriosclerosis, thrombosis, and vascular biology.

[22]  Markus G. Manz,et al.  Development of Monocytes, Macrophages, and Dendritic Cells , 2010, Science.

[23]  M. Cybulsky,et al.  Resident Intimal Dendritic Cells Accumulate Lipid and Contribute to the Initiation of Atherosclerosis , 2010, Circulation research.

[24]  Claudio Lottaz,et al.  Comparison of gene expression profiles between human and mouse monocyte subsets. , 2010, Blood.

[25]  F. Geissmann,et al.  Monocytes in atherosclerosis: subsets and functions , 2010, Nature Reviews Cardiology.

[26]  C. Gleissner,et al.  CXCL4 Downregulates the Atheroprotective Hemoglobin Receptor CD163 in Human Macrophages , 2010, Circulation Research.

[27]  Yunshan Cao,et al.  Expression of Toll-Like Receptor 4, Tumor Necrosis Factor- Alpha, Matrix Metalloproteinase-9 and Effects of Benazepril in Patients with Acute Coronary Syndromes , 2010, Clinical Medicine Insights. Cardiology.

[28]  C. Weyand,et al.  Dendritic cells in atherosclerotic disease. , 2010, Clinical immunology.

[29]  I. Tabas Macrophage death and defective inflammation resolution in atherosclerosis , 2010, Nature Reviews Immunology.

[30]  P. Giral,et al.  Stimulation of Cholesterol Efflux by LXR Agonists in Cholesterol-Loaded Human Macrophages Is ABCA1-Dependent but ABCG1-Independent , 2009, Arteriosclerosis, thrombosis, and vascular biology.

[31]  Soo-Ho Choi,et al.  Toll-like receptor-4 and lipoprotein accumulation in macrophages. , 2009, Trends in cardiovascular medicine.

[32]  R. Weissleder,et al.  Heterogeneous in vivo behavior of monocyte subsets in atherosclerosis. , 2009, Arteriosclerosis, thrombosis, and vascular biology.

[33]  C. Garlanda,et al.  Macrophage diversity and polarization in atherosclerosis: a question of balance. , 2009, Arteriosclerosis, thrombosis, and vascular biology.

[34]  A. Vaughan,et al.  The Macrophage Cholesterol Exporter ABCA1 Functions as an Anti-inflammatory Receptor* , 2009, The Journal of Biological Chemistry.

[35]  Steffen Jung,et al.  Intestinal lamina propria dendritic cell subsets have different origin and functions. , 2009, Immunity.

[36]  C. Hedrick,et al.  Murine 12/15-Lipoxygenase Regulates ATP-binding Cassette Transporter G1 Protein Degradation through p38- and JNK2-dependent Pathways* , 2009, The Journal of Biological Chemistry.

[37]  P. Libby,et al.  Identification of Splenic Reservoir Monocytes and Their Deployment to Inflammatory Sites , 2009, Science.

[38]  Andrew C. Li,et al.  Lipoprotein Accumulation in Macrophages via Toll-Like Receptor-4-Dependent Fluid Phase Uptake , 2009, Circulation research.

[39]  H. Kruth,et al.  Fluorescent pegylated nanoparticles demonstrate fluid-phase pinocytosis by macrophages in mouse atherosclerotic lesions. , 2009, The Journal of clinical investigation.

[40]  Miriam Merad,et al.  Dendritic cell homeostasis. , 2009, Blood.

[41]  F. Geissmann,et al.  Blood monocytes: development, heterogeneity, and relationship with dendritic cells. , 2009, Annual review of immunology.

[42]  K. Ley,et al.  Immune and inflammatory mechanisms of atherosclerosis (*). , 2009, Annual review of immunology.

[43]  S. Gordon,et al.  Alternative activation of macrophages: an immunologic functional perspective. , 2009, Annual review of immunology.

[44]  C. Weber,et al.  Myeloid cells in atherosclerosis: initiators and decision shapers , 2009, Seminars in Immunopathology.

[45]  Irving L. Weissman,et al.  CX3CR1 is required for monocyte homeostasis and atherogenesis by promoting cell survival. , 2009, Blood.

[46]  Steffen Jung,et al.  Origins and tissue‐context‐dependent fates of blood monocytes , 2009, Immunology and cell biology.

[47]  K. Moore,et al.  Loss of SR-A and CD36 Activity Reduces Atherosclerotic Lesion Complexity Without Abrogating Foam Cell Formation in Hyperlipidemic Mice , 2009, Arteriosclerosis, thrombosis, and vascular biology.

[48]  R. Silverstein,et al.  CD36 modulates migration of mouse and human macrophages in response to oxidized LDL and may contribute to macrophage trapping in the arterial intima. , 2008, The Journal of clinical investigation.

[49]  Steffen Jung,et al.  Probing in vivo origins of mononuclear phagocytes by conditional ablation and reconstitution. , 2009, Methods in molecular biology.

[50]  A. Zernecke,et al.  Disrupting functional interactions between platelet chemokines inhibits atherosclerosis in hyperlipidemic mice , 2009, Nature Medicine.

[51]  Marnie L. Gruen,et al.  Impact of macrophage toll-like receptor 4 deficiency on macrophage infiltration into adipose tissue and the artery wall in mice , 2009, Diabetologia.

[52]  B. Staels,et al.  Liver X Receptor Activation Induces the Uptake of Cholesteryl Esters From High Density Lipoproteins in Primary Human Macrophages , 2008, Arteriosclerosis, thrombosis, and vascular biology.

[53]  A. Tall,et al.  Increased Inflammatory Gene Expression in ABC Transporter–Deficient Macrophages: Free Cholesterol Accumulation, Increased Signaling via Toll-Like Receptors, and Neutrophil Infiltration of Atherosclerotic Lesions , 2008, Circulation.

[54]  C. Serhan,et al.  Atherosclerosis: evidence for impairment of resolution of vascular inflammation governed by specific lipid mediators , 2008, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[55]  P. Libby,et al.  The multifaceted contributions of leukocyte subsets to atherosclerosis: lessons from mouse models , 2008, Nature Reviews Immunology.

[56]  C. Hedrick,et al.  12/15-Lipoxygenase Activity Increases the Degradation of Macrophage ATP-Binding Cassette Transporter G1 , 2008, Arteriosclerosis, thrombosis, and vascular biology.

[57]  F. Geissmann,et al.  Blood monocytes: distinct subsets, how they relate to dendritic cells, and their possible roles in the regulation of T‐cell responses , 2008, Immunology and cell biology.

[58]  Huan Wang,et al.  P-Selectin Glycoprotein Ligand-1 Is Highly Expressed on Ly-6Chi Monocytes and a Major Determinant for Ly-6Chi Monocyte Recruitment to Sites of Atherosclerosis in Mice , 2008, Circulation.

[59]  C. Ayers,et al.  Reduced Expression of ATP-Binding Cassette Transporter G1 Increases Cholesterol Accumulation in Macrophages of Patients With Type 2 Diabetes Mellitus , 2008, Circulation.

[60]  R. Proia,et al.  Sphingosine-1-Phosphate Induces an Antiinflammatory Phenotype in Macrophages , 2008, Circulation research.

[61]  T. Simon,et al.  Combined Inhibition of CCL2, CX3CR1, and CCR5 Abrogates Ly6Chi and Ly6Clo Monocytosis and Almost Abolishes Atherosclerosis in Hypercholesterolemic Mice , 2008, Circulation.

[62]  T. Hohl,et al.  Monocyte-mediated defense against microbial pathogens. , 2008, Annual review of immunology.

[63]  Alberto Mantovani,et al.  Macrophage activation and polarization. , 2008, Frontiers in bioscience : a journal and virtual library.

[64]  F. Rossi,et al.  Local self-renewal can sustain CNS microglia maintenance and function throughout adult life , 2007, Nature Neuroscience.

[65]  K. Ley,et al.  Leukocyte influx in atherosclerosis. , 2007, Current drug targets.

[66]  Ulrich H. von Andrian,et al.  Immunosurveillance by Hematopoietic Progenitor Cells Trafficking through Blood, Lymph, and Peripheral Tissues , 2007, Cell.

[67]  B. Sachais,et al.  Elimination of platelet factor 4 (PF4) from platelets reduces atherosclerosis in C57Bl/6 and apoE-/- mice , 2007, Thrombosis and Haemostasis.

[68]  D. Jarrossay,et al.  Identification of clonogenic common Flt3+M-CSFR+ plasmacytoid and conventional dendritic cell progenitors in mouse bone marrow , 2007, Nature Immunology.

[69]  F. Luscinskas,et al.  JAM-C regulates unidirectional monocyte transendothelial migration in inflammation. , 2007, Blood.

[70]  K. Kaestner,et al.  The Kruppel‐like factor KLF4 is a critical regulator of monocyte differentiation , 2007, The EMBO journal.

[71]  M. Cybulsky,et al.  Getting to the site of inflammation: the leukocyte adhesion cascade updated , 2007, Nature Reviews Immunology.

[72]  A. Cumano,et al.  Monitoring of Blood Vessels and Tissues by a Population of Monocytes with Patrolling Behavior , 2007, Science.

[73]  J. Milbrandt,et al.  Abrogation of nuclear receptors Nr4a3 andNr4a1 leads to development of acute myeloid leukemia , 2007, Nature Medicine.

[74]  K. Ley,et al.  Platelet-neutrophil-interactions: linking hemostasis and inflammation. , 2007, Blood reviews.

[75]  Steffen Jung,et al.  Monocytes give rise to mucosal, but not splenic, conventional dendritic cells , 2007, The Journal of experimental medicine.

[76]  F. Tacke,et al.  Monocyte subsets differentially employ CCR2, CCR5, and CX3CR1 to accumulate within atherosclerotic plaques. , 2007, The Journal of clinical investigation.

[77]  P. Libby,et al.  Ly-6Chi monocytes dominate hypercholesterolemia-associated monocytosis and give rise to macrophages in atheromata. , 2007, The Journal of clinical investigation.

[78]  J. Boyle,et al.  Complement C1q reduces early atherosclerosis in low-density lipoprotein receptor-deficient mice. , 2007, The American journal of pathology.

[79]  Stanley L. Hazen,et al.  Oxidized phosphatidylserine–CD36 interactions play an essential role in macrophage-dependent phagocytosis of apoptotic cells , 2006, The Journal of experimental medicine.

[80]  Alberto Mantovani,et al.  Transcriptional Profiling of the Human Monocyte-to-Macrophage Differentiation and Polarization: New Molecules and Patterns of Gene Expression1 , 2006, The Journal of Immunology.

[81]  F. Tacke,et al.  Migratory fate and differentiation of blood monocyte subsets. , 2006, Immunobiology.

[82]  M. Cybulsky,et al.  Low-grade chronic inflammation in regions of the normal mouse arterial intima predisposed to atherosclerosis , 2006, The Journal of experimental medicine.

[83]  C. Hedrick,et al.  Reduction in ABCG1 in Type 2 Diabetic Mice Increases Macrophage Foam Cell Formation* , 2006, Journal of Biological Chemistry.

[84]  P. Libby,et al.  Monocyte accumulation in mouse atherogenesis is progressive and proportional to extent of disease , 2006, Proceedings of the National Academy of Sciences.

[85]  M. Daha,et al.  IL-10-producing macrophages preferentially clear early apoptotic cells. , 2006, Blood.

[86]  Elena Galkina,et al.  Lymphocyte recruitment into the aortic wall before and during development of atherosclerosis is partially L-selectin dependent , 2006, The Journal of experimental medicine.

[87]  J. Witztum,et al.  Minimally Oxidized LDL Offsets the Apoptotic Effects of Extensively Oxidized LDL and Free Cholesterol in Macrophages , 2006, Arteriosclerosis, thrombosis, and vascular biology.

[88]  F. Tacke,et al.  Gene expression changes in foam cells and the role of chemokine receptor CCR7 during atherosclerosis regression in ApoE-deficient mice. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[89]  S. Hazen,et al.  A CD36‐dependent signaling cascade is necessary for macrophage foam cell formation , 2006, Cell metabolism.

[90]  Li Zhou,et al.  Increased expression of Toll like receptor 4 on peripheral‐blood mononuclear cells in patients with coronary arteriosclerosis disease , 2006, Clinical and experimental immunology.

[91]  Ana Cumano,et al.  A Clonogenic Bone Marrow Progenitor Specific for Macrophages and Dendritic Cells , 2006, Science.

[92]  S. Watson,et al.  Cellular Pathology of Atherosclerosis: Smooth Muscle Cells Promote Adhesion of Platelets to Cocultured Endothelial Cells , 2005, Circulation research.

[93]  I. Tabas Consequences and Therapeutic Implications of Macrophage Apoptosis in Atherosclerosis: The Importance of Lesion Stage and Phagocytic Efficiency , 2005, Arteriosclerosis, thrombosis, and vascular biology.

[94]  A. Sica,et al.  Macrophage polarization comes of age. , 2005, Immunity.

[95]  Jennifer Y. King,et al.  Pathway analysis of coronary atherosclerosis. , 2005, Physiological genomics.

[96]  Y. Bobryshev Dendritic cells in atherosclerosis: current status of the problem and clinical relevance. , 2005, European heart journal.

[97]  K. Ley,et al.  Macrophage differentiation to foam cells. , 2005, Current pharmaceutical design.

[98]  J. Witztum,et al.  You are right too! , 2005, The Journal of clinical investigation.

[99]  K. Moore,et al.  Loss of receptor-mediated lipid uptake via scavenger receptor A or CD36 pathways does not ameliorate atherosclerosis in hyperlipidemic mice. , 2005, The Journal of clinical investigation.

[100]  H. Methe,et al.  Expansion of Circulating Toll-Like Receptor 4–Positive Monocytes in Patients With Acute Coronary Syndrome , 2005, Circulation.

[101]  Paul T. Tarr,et al.  ABCG1 has a critical role in mediating cholesterol efflux to HDL and preventing cellular lipid accumulation. , 2005, Cell metabolism.

[102]  D. Malide,et al.  Macropinocytosis Is the Endocytic Pathway That Mediates Macrophage Foam Cell Formation with Native Low Density Lipoprotein* , 2005, Journal of Biological Chemistry.

[103]  M. Linton,et al.  Reduced Macrophage Apoptosis Is Associated With Accelerated Atherosclerosis in Low-Density Lipoprotein Receptor–Null Mice , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[104]  Roger A. Davis,et al.  Differential inhibition of macrophage foam-cell formation and atherosclerosis in mice by PPARα, β/δ, and γ , 2004 .

[105]  Andrew C. Li,et al.  PPAR- and LXR-dependent pathways controlling lipid metabolism and the development of atherosclerosis Published, JLR Papers in Press, October 16, 2004. DOI 10.1194/jlr.R400010-JLR200 , 2004, Journal of Lipid Research.

[106]  W. Muller,et al.  Platelet Endothelial Cell Adhesion Molecule Deficiency or Blockade Significantly Reduces Leukocyte Emigration in a Majority of Mouse Strains , 2004, The Journal of Immunology.

[107]  I. Weissman,et al.  JunB Deficiency Leads to a Myeloproliferative Disorder Arising from Hematopoietic Stem Cells , 2004, Cell.

[108]  Peter Tontonoz,et al.  Nuclear receptors in macrophage biology: at the crossroads of lipid metabolism and inflammation. , 2004, Annual review of cell and developmental biology.

[109]  K. Ley,et al.  Critical Role of Macrophage 12/15-Lipoxygenase for Atherosclerosis in Apolipoprotein E–Deficient Mice , 2004, Circulation.

[110]  E. Fisher,et al.  Emigration of monocyte-derived cells from atherosclerotic lesions characterizes regressive, but not progressive, plaques. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[111]  M. Cybulsky,et al.  Leukocyte recruitment to atherosclerotic lesions. , 2004, The Canadian journal of cardiology.

[112]  J. Mehta The role of LOX-1, a novel lectin-like receptor for oxidized low density lipoprotein, in atherosclerosis. , 2004, The Canadian journal of cardiology.

[113]  S. Akira,et al.  Lack of Toll-like receptor 4 or myeloid differentiation factor 88 reduces atherosclerosis and alters plaque phenotype in mice deficient in apolipoprotein E. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[114]  A. Tall,et al.  ATP-binding cassette transporters G1 and G4 mediate cellular cholesterol efflux to high-density lipoproteins. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[115]  T. Handel,et al.  Identification of the Glycosaminoglycan Binding Site of the CC Chemokine, MCP-1 , 2004, Journal of Biological Chemistry.

[116]  R. Natarajan,et al.  12/15-Lipoxygenase Activity Mediates Inflammatory Monocyte/Endothelial Interactions and Atherosclerosis in Vivo* , 2004, Journal of Biological Chemistry.

[117]  C. Clish,et al.  Reduced Inflammation and Tissue Damage in Transgenic Rabbits Overexpressing 15-Lipoxygenase and Endogenous Anti-inflammatory Lipid Mediators 1 , 2003, The Journal of Immunology.

[118]  M. Linton,et al.  Macrophages, inflammation, and atherosclerosis , 2003, International Journal of Obesity.

[119]  D. S. Worrall,et al.  Actin polymerization in macrophages in response to oxidized LDL and apoptotic cells: role of 12/15-lipoxygenase and phosphoinositide 3-kinase. , 2003, Molecular biology of the cell.

[120]  J. Hogg,et al.  A novel method to quantify the turnover and release of monocytes from the bone marrow using the thymidine analog 5'-bromo-2'-deoxyuridine. , 2003, American journal of physiology. Cell physiology.

[121]  S. Gordon,et al.  Monocyte heterogeneity and innate immunity. , 2003, Immunity.

[122]  E. Pamer,et al.  TNF/iNOS-producing dendritic cells mediate innate immune defense against bacterial infection. , 2003, Immunity.

[123]  Steffen Jung,et al.  Blood monocytes consist of two principal subsets with distinct migratory properties. , 2003, Immunity.

[124]  G. Feldman,et al.  Interleukin-13 Induction of 15-Lipoxygenase Gene Expression Requires p38 Mitogen-Activated Protein Kinase-Mediated Serine 727 Phosphorylation of Stat1 and Stat3 , 2003, Molecular and Cellular Biology.

[125]  D. Mangelsdorf,et al.  Liver X receptor signaling pathways in cardiovascular disease. , 2003, Molecular endocrinology.

[126]  P. Burger,et al.  Platelet P-selectin facilitates atherosclerotic lesion development. , 2003, Blood.

[127]  J. Witztum,et al.  Minimally Modified LDL Binds to CD14, Induces Macrophage Spreading via TLR4/MD-2, and Inhibits Phagocytosis of Apoptotic Cells* , 2003, The Journal of Biological Chemistry.

[128]  Andreas Schober,et al.  Circulating activated platelets exacerbate atherosclerosis in mice deficient in apolipoprotein E , 2003, Nature Medicine.

[129]  K. Moore,et al.  Scavenger Receptors Class A-I/II and CD36 Are the Principal Receptors Responsible for the Uptake of Modified Low Density Lipoprotein Leading to Lipid Loading in Macrophages* , 2002, The Journal of Biological Chemistry.

[130]  S. Hazen,et al.  A Novel Family of Atherogenic Oxidized Phospholipids Promotes Macrophage Foam Cell Formation via the Scavenger Receptor CD36 and Is Enriched in Atherosclerotic Lesions* , 2002, Journal of Biological Chemistry.

[131]  Yijun Deng,et al.  Identification of a Novel Family of Oxidized Phospholipids That Serve as Ligands for the Macrophage Scavenger Receptor CD36* , 2002, The Journal of Biological Chemistry.

[132]  M. Gawaz,et al.  A Critical Role of Platelet Adhesion in the Initiation of Atherosclerotic Lesion Formation , 2002, The Journal of experimental medicine.

[133]  M. Cathcart,et al.  IL‐13 signal transduction in human monocytes: phosphorylation of receptor components, association with Jaks, and phosphorylation/activation of Stats , 2002, Journal of leukocyte biology.

[134]  A. Lusis,et al.  Identification of 5-Lipoxygenase as a Major Gene Contributing to Atherosclerosis Susceptibility in Mice , 2002, Circulation research.

[135]  P. Libby,et al.  Inflammation and Atherosclerosis , 2002, Circulation.

[136]  R. Russell,et al.  Targeted disruption of the mouse colony-stimulating factor 1 receptor gene results in osteopetrosis, mononuclear phagocyte deficiency, increased primitive progenitor cell frequencies, and reproductive defects. , 2002, Blood.

[137]  Steffen Jung,et al.  The chemokine KC, but not monocyte chemoattractant protein-1, triggers monocyte arrest on early atherosclerotic endothelium. , 2001, The Journal of clinical investigation.

[138]  V. Fadok,et al.  Apoptotic cell removal , 2001, Current Biology.

[139]  A. Tall,et al.  ATP-binding Cassette Transporter A1 (ABCA1) Functions as a Cholesterol Efflux Regulatory Protein* , 2001, The Journal of Biological Chemistry.

[140]  J. Witztum,et al.  12/15-Lipoxygenase Translocation Enhances Site-specific Actin Polymerization in Macrophages Phagocytosing Apoptotic Cells* , 2001, The Journal of Biological Chemistry.

[141]  M. Cybulsky,et al.  A major role for VCAM-1, but not ICAM-1, in early atherosclerosis. , 2001, The Journal of clinical investigation.

[142]  R. Lawn,et al.  ABCA1. The gatekeeper for eliminating excess tissue cholesterol. , 2001, Journal of lipid research.

[143]  D. Rader,et al.  Absence of 12/15-Lipoxygenase Expression Decreases Lipid Peroxidation and Atherogenesis in Apolipoprotein E—Deficient Mice , 2001, Circulation.

[144]  J. Oram Novel approaches to treating cardiovascular disease: lessons from Tangier disease , 2001, Expert opinion on investigational drugs.

[145]  B. Hoffman,et al.  Early growth response gene 1 stimulates development of hematopoietic progenitor cells along the macrophage lineage at the expense of the granulocyte and erythroid lineages. , 2001, Blood.

[146]  E. Wagner,et al.  Chronic Myeloid Leukemia with Increased Granulocyte Progenitors in Mice Lacking JunB Expression in the Myeloid Lineage , 2001, Cell.

[147]  K. Ozato,et al.  Transcription Factors that Regulate Growth and Differentiation of Myeloid Cells , 2001, International reviews of immunology.

[148]  R. Evans,et al.  A PPARγ-LXR-ABCA1 Pathway in Macrophages Is Involved in Cholesterol Efflux and Atherogenesis , 2001 .

[149]  R. Evans,et al.  PPAR-γ dependent and independent effects on macrophage-gene expression in lipid metabolism and inflammation , 2001, Nature Medicine.

[150]  K. Ozato,et al.  ICSBP directs bipotential myeloid progenitor cells to differentiate into mature macrophages. , 2000, Immunity.

[151]  K. Ley,et al.  Role of vascular cell adhesion molecule-1 and fibronectin connecting segment-1 in monocyte rolling and adhesion on early atherosclerotic lesions. , 2000, Circulation research.

[152]  E. Wagner,et al.  JunB suppresses cell proliferation by transcriptional activation of p16INK4a expression , 2000, The EMBO journal.

[153]  E. Bossy‐Wetzel,et al.  Cell cycle‐dependent variations in c‐Jun and JunB phosphorylation: a role in the control of cyclin D1 expression , 2000, The EMBO journal.

[154]  S. Hazen,et al.  Targeted disruption of the class B scavenger receptor CD36 protects against atherosclerotic lesion development in mice. , 2000, The Journal of clinical investigation.

[155]  L. Lindbom,et al.  Direct observations in vivo on the role of endothelial selectins and alpha(4) integrin in cytokine-induced leukocyte-endothelium interactions in the mouse aorta. , 2000, Circulation research.

[156]  R. Ross Atherosclerosis is an inflammatory disease , 1999 .

[157]  R. Ashmun,et al.  c-Maf induces monocytic differentiation and apoptosis in bipotent myeloid progenitors. , 1999, Blood.

[158]  K. Ley,et al.  Direct demonstration of P-selectin- and VCAM-1-dependent mononuclear cell rolling in early atherosclerotic lesions of apolipoprotein E-deficient mice. , 1999, Circulation research.

[159]  D. Rader,et al.  Disruption of the 12/15-lipoxygenase gene diminishes atherosclerosis in apo E-deficient mice. , 1999, The Journal of clinical investigation.

[160]  F. Luscinskas,et al.  MCP-1 and IL-8 trigger firm adhesion of monocytes to vascular endothelium under flow conditions , 1999, Nature.

[161]  M. Cathcart,et al.  Induction of 15-Lipoxygenase Expression by IL-13 Requires Tyrosine Phosphorylation of Jak2 and Tyk2 in Human Monocytes* , 1998, The Journal of Biological Chemistry.

[162]  R. Evans,et al.  PPARγ Promotes Monocyte/Macrophage Differentiation and Uptake of Oxidized LDL , 1998, Cell.

[163]  R. Becker,et al.  Increased platelet reactivity and circulating monocyte-platelet aggregates in patients with stable coronary artery disease. , 1998, Journal of the American College of Cardiology.

[164]  P. Reaven,et al.  Fibroblasts that overexpress 15-lipoxygenase generate bioactive and minimally modified LDL. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[165]  J. Cornhill,et al.  Macrophage-mediated 15-lipoxygenase expression protects against atherosclerosis development. , 1996, The Journal of clinical investigation.

[166]  W. Wiktor-Jedrzejczak,et al.  Cytokine regulation of the macrophage (M phi) system studied using the colony stimulating factor-1-deficient op/op mouse. , 1996, Physiological reviews.

[167]  A. Feeney,et al.  Targeted disruption of the PU.1 gene results in multiple hematopoietic abnormalities. , 1996, The EMBO journal.

[168]  R. Natarajan,et al.  A 12-lipoxygenase product, 12-hydroxyeicosatetraenoic acid, is increased in diabetics with incipient and early renal disease. , 1996, The Journal of clinical endocrinology and metabolism.

[169]  L. Chan,et al.  Transgenic rabbits with the integrated human 15‐lipoxygenase gene driven by a lysozyme promoter: macrophage‐specific expression and variable positional specificity of the transgenic enzyme , 1995, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[170]  C. Glass,et al.  Neutrophils and monocytes express high levels of PU.1 (Spi-1) but not Spi-B. , 1995, Blood.

[171]  M. Modolell,et al.  Reciprocal regulation of the nitric oxide synthase/arginase balance in mouse bone marrow‐derived macrophages by TH 1 and TH 2 cytokines , 1995, European journal of immunology.

[172]  W. Muller The role of PECAM‐1 (CD31) in leukocyte emigration: studies in vitro and in vivo , 1995, Journal of leukocyte biology.

[173]  D. Steinberg,et al.  Enhanced Levels of Lipoperoxides in Low Density Lipoprotein Incubated with Murine Fibroblasts Expressing High Levels of Human 15-Lipoxygenase (*) , 1995, The Journal of Biological Chemistry.

[174]  Melinda Fitzgerald,et al.  Immunol. Cell Biol. , 1995 .

[175]  E. Scott,et al.  Requirement of transcription factor PU.1 in the development of multiple hematopoietic lineages. , 1994, Science.

[176]  M. Cybulsky,et al.  Increased expression in vivo of VCAM-1 and E-selectin by the aortic endothelium of normolipemic and hyperlipemic diabetic rabbits. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.

[177]  T. Springer Traffic signals for lymphocyte recirculation and leukocyte emigration: The multistep paradigm , 1994, Cell.

[178]  M. Klemsz,et al.  Hematopoietic lineage- and stage-restricted expression of the ETS oncogene family member PU.1. , 1993, Blood.

[179]  D. Liebermann,et al.  Proto-oncogenes of the fos/jun family of transcription factors are positive regulators of myeloid differentiation , 1993, Molecular and cellular biology.

[180]  D. Liebermann,et al.  The zinc finger transcription factor Egr-1 is essential for and restricts differentiation along the macrophage lineage , 1993, Cell.

[181]  D. Steinberg,et al.  Gene expression in macrophage-rich human atherosclerotic lesions. 15-lipoxygenase and acetyl low density lipoprotein receptor messenger RNA colocalize with oxidation specific lipid-protein adducts. , 1991, The Journal of clinical investigation.

[182]  F. Mollinedo,et al.  Expression of c-jun, jun B and jun D proto-oncogenes in human peripheral-blood granulocytes. , 1991, The Biochemical journal.

[183]  C. Glass,et al.  Colocalization of 15-lipoxygenase mRNA and protein with epitopes of oxidized low density lipoprotein in macrophage-rich areas of atherosclerotic lesions. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[184]  B. Passlick,et al.  Identification and characterization of a novel monocyte subpopulation in human peripheral blood. , 1989, Blood.

[185]  R. Furth Origin and turnover of monocytes and macrophages. , 1989 .

[186]  R. Furth,et al.  Dual origin of mouse spleen macrophages. , 1984 .

[187]  Gerrity Rg The role of the monocyte in atherogenesis: I. Transition of blood-borne monocytes into foam cells in fatty lesions. , 1981 .

[188]  R. Gerrity,et al.  The role of the monocyte in atherogenesis: II. Migration of foam cells from atherosclerotic lesions. , 1981, The American journal of pathology.

[189]  R. Gerrity The role of the monocyte in atherogenesis: I. Transition of blood-borne monocytes into foam cells in fatty lesions. , 1981, The American journal of pathology.

[190]  Gerrity Rg,et al.  Ultrastructural identification of monocyte-derived foam cells in fatty streak lesions. , 1980 .

[191]  R. Gerrity,et al.  Ultrastructural identification of monocyte-derived foam cells in fatty streak lesions. , 1980, Artery.

[192]  L. Horlick Platelet adhesiveness in normal persons and subjects with atherosclerosis. Effect of high fat meals and anti-coagulants on the adhesive index. , 1961, The American journal of cardiology.